Cognition Therapeutics In...

NASDAQ: CGTX · Real-Time Price · USD
1.54
-0.12 (-7.23%)
At close: Aug 15, 2025, 3:59 PM
1.58
2.25%
Pre-market: Aug 18, 2025, 08:33 AM EDT

Cognition Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-33.97M -25.79M -21.4M -11.72M
Depreciation & Amortization
266K 252K 235K 93K
Stock-Based Compensation
3.75M 4.35M 3.57M 5.18M
Other Working Capital
2.69M 2.46M 1.55M 1.79M
Other Non-Cash Items
195K 318K 6.54M 383K
Deferred Income Tax
n/a n/a -6.54M -416K
Change in Working Capital
1.29M 4.85M -943K 2.84M
Operating Cash Flow
-28.47M -16.02M -18.53M -3.63M
Capital Expenditures
-4K -147K -171K -27K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-4K -147K -171K -27K
Debt Repayment
-739K -811K -1.4M -268K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-46K n/a 1.62M 9.25M
Financial Cash Flow
23.57M 4.52M 5.55M 53.2M
Net Cash Flow
-4.91M -11.64M -13.16M 49.53M
Free Cash Flow
-28.48M -16.16M -18.7M -3.66M